ReviewGenes & diseases2023

Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics.

Uttpal Anand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.